Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-13, Stock:ABBV, The news for the past five days is as follows:
2019-12-06: NEWS1: Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting.NEWS2: Belgium's UCB says psoriasis drug beats AbbVie's Humira in trial.NEWS3: AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis.
2019-12-09: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.NEWS2: World's largest biotech company to move up to BioMed's big South City project.NEWS3: J&J Presents Data on CAR-T Therapy Drug and Imbruvica at ASH.NEWS4: Sanofi to Buy Synthorx for $2.5B to Boost Cancer Portfolio.NEWS5: 3 Top Dividend Stocks to Maximize Your Retirement Income - December 09, 2019.NEWS6: Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay.NEWS7: AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics.
2019-12-10: NEWS1: Biotech ETFs Hit New Highs on Deal Activities.NEWS2: Merck Stock Is On An Upswing In 2019 — Should You Buy This Pharma Stock?.NEWS3: Drug manufacturers have spent a record $342 billion on M&A in 2019.
2019-12-11: NEWS1: Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - December 11, 2019.NEWS2: Vertex's Kalydeco Gets EU Approval to Treat CF in Infants.NEWS3: Top Research Reports for Novartis, AbbVie & Sanofi.
2019-12-12: NEWS1: Seattle Genetics' Cancer Study Boosts Prospects, Takeover Appeal.NEWS2: AbbVie's 2019 Points to the End of the Efficient Market Thesis - Cramer.NEWS3: The Zacks Analyst Blog Highlights: Novartis, AbbVie, Sanofi, Pioneer Natural Resources and Aqua America.NEWS4: 3 Investing Facts About Required Minimum Distributions You Need to Know - December 12, 2019.NEWS5: Should We Worry About AbbVie Inc.'s (NYSE:ABBV) P/E Ratio?.

Answer: Decrease